Stock Scorecard
Stock Summary for Biotricity Inc (BTCY) - $1.33 as of 5/1/2024 8:04:49 PM EST
Total Score
9 out of 29
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for BTCY
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BTCY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BTCY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for BTCY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for BTCY
Financial Details for BTCY
Company Overview |
|
|---|---|
| Ticker | BTCY |
| Company Name | Biotricity Inc |
| Country | USA |
| Description | Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company is headquartered in Redwood City, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 6/28/2024 |
Stock Price History |
|
| Last Day Price | 1.33 |
| Last Day Price Updated | 5/1/2024 8:04:49 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 111,705 |
| 52-Week High | 4.37 |
| 52-Week Low | 0.70 |
| Last Price to 52 Week Low | 90.00% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 47.24 |
| Sector PE | 53.36 |
| 5-Year Average PE | -17.27 |
| Free Cash Flow Ratio | 133.00 |
| Industry Free Cash Flow Ratio | 61.63 |
| Sector Free Cash Flow Ratio | 30.86 |
| Current Ratio Most Recent Quarter | 0.21 |
| Total Cash Per Share | 0.01 |
| Book Value Per Share Most Recent Quarter | -2.95 |
| Price to Book Ratio | 33.02 |
| Industry Price to Book Ratio | 5.21 |
| Sector Price to Book Ratio | 22.00 |
| Price to Sales Ratio Twelve Trailing Months | 0.94 |
| Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.14 |
Share Statistics |
|
| Total Shares Outstanding | 9,308,800 |
| Market Capitalization | 12,380,704 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 35.95% |
| Reported EPS 12 Trailing Months | -1.75 |
| Reported EPS Past Year | -1.19 |
| Reported EPS Prior Year | -0.82 |
| Net Income Twelve Trailing Months | -14,584,041 |
| Net Income Past Year | -18,658,143 |
| Net Income Prior Year | -29,130,477 |
| Quarterly Revenue Growth YOY | 20.90% |
| 5-Year Revenue Growth | 121.81% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 85,094 |
| Total Cash Past Year | 570,460 |
| Total Cash Prior Year | 12,066,929 |
| Net Cash Position Most Recent Quarter | -21,326,126 |
| Net Cash Position Past Year | -17,253,617 |
| Long Term Debt Past Year | 17,824,077 |
| Long Term Debt Prior Year | 14,023,472 |
| Total Debt Most Recent Quarter | 21,411,220 |
| Equity to Debt Ratio Past Year | 0.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.00 |
| Total Stockholder Equity Past Year | -19,845,385 |
| Total Stockholder Equity Prior Year | -2,144,736 |
| Total Stockholder Equity Most Recent Quarter | -27,756,354 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.03 |
| MACD Signal | 0.03 |
| 20-Day Bollinger Lower Band | 0.76 |
| 20-Day Bollinger Middle Band | 1.15 |
| 20-Day Bollinger Upper Band | 1.54 |
| Beta | 1.54 |
| RSI | 47.07 |
| 50-Day SMA | 1.89 |
| 200-Day SMA | 8.88 |
System |
|
| Modified | 5/1/2024 8:00:44 PM EST |